Business
Aptus Pharma Ltd. Press Release Apr 28 2026
Statement of Deviation(s) or Variation(s) in utilization of proceeds of initial Public Offer pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
About this update from Aptus Pharma Ltd.
Statement of Deviation(s) or Variation(s) in utilization of proceeds of initial Public Offer pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 View Attachment